Michelle Alana Iocolano, MD

Friedes C, Iocolano M, Yegya-Raman N, Kucharczuk JC, Pechet TTV, Cohen RB, Aggarwal C, Marmarelis ME, Levin WP, Cengel KA, Ciunci CA, D'Avella C, Singh AP, Davis CW, Langer CJ, Bradley J, Feigenberg SJ. Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy , Am J Clin Oncol, 49: 2026,212-218

Friedes C, Yegya-Raman N, Iocolano M, Levin WP, Cengel KA, Bradley JD, Feigenberg SJ. Primary Tumor Failure After Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008 , Int J Radiat Oncol Biol Phys, 124: 2026,305-310

Rocchetti J, Yegya-Raman N, Iocolano M, Levin WP, Cengel KA, Bradley J, Feigenberg SJ, Friedes C Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy , Radiother Oncol, 208: 2025,110911

Iocolano M, Vachani C, Bach C, Arnold-Korzeniowski K, Metz JMM, Hill-Kayser C Patient Reported Outcomes and Patterns of Care after Proton Beam Therapy (PRT) for Gastrointestinal (GI) Cancers , 66th Annual American Society for Radiation Oncology (ASTRO) Meeting, Washington, DC: 2024

Iocolano M, Yegya-Raman N, Wang X, Friedes C, Lee SH, Duan L, Li B, Levin WP, Cengel KA, Langer C, Cohen R, Sun L, Aggarwal C, Doucette A, Xiao Y, Teo K, O'Reilly SE, Zou W, Bradley JD, Feigenberg SJ Unplanned Hospitalizations and Lymphopenia after Proton Beam Therapy (PBT) vs. Intensity-Modulated Radiation Therapy (IMRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): An Analysis of 746 Patients , 66th Annual American Society for Radiation Oncology (ASTRO) Meeting, Washington, DC: 2024

Iocolano M, Yegya-Raman N, Friedes C, Wang X, Kegelman T, Lee SH, Duan L, Li B, Levin WP, Cengel KA, Konski A, Langer CJ, Cohen RB, Sun L, Aggarwal C, Doucette A, Xiao Y, Kevin Teo BK, O'Reilly S, Zou W, Bradley JD, Simone CB 2nd, Feigenberg SJ Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era , Cancer, 130(11): 2024,2031-2041

Yegya-Raman N, Berman AT, Ciunci CA, Friedes C, Berlin E, Iocolano M, Wang X, Lai C, Levin WP, Cengel KA, O'Reilly SE, Cohen RB, Aggarwal C, Marmarelis ME, Singh AP, Sun L, Bradley JD, Plastaras JP, Simone CB 2nd, Langer CJ, Feigenberg SJ Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer , Int J Radiat Oncol Biol Phys, 119(1): 2024,56-65

locolano M, Vachani C, Bach C, Arnold-Korzeniowski K, Metz J, & Hill-Kayser C Patterns of Care and Long-Term Toxicity Among Breast Cancer Survivorship Care Plan Users Who Received Proton Radiotherapy , 106th Annual Meeting, American Radium Society, Palm Springs, CA: 2024

Barsouk A, Friedes C, Iocolano M, Doucette A, Cohen RB, Robinson KW, D'Avella CA, Marmarelis ME, Kosteva JA, Singh AP, Ciunci CA, Levin WP, Cengel KA, Bradley JD, Feigenberg SJ, Sun L, Aggarwal C, Langer CJ, Yegya-Raman N Plunging Into the PACIFIC: Outcomes of Patients with Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation , Clin Lung Cancer, 25(3): 2024,e161-e171

Friedes C, Iocolano M, Lee SH, Li B, Duan L, Levin WP, Cengel KA, Sun LL, Aggarwal C, Marmarelis ME, Doucette A, Cohen RB, Xiao Y, Langer CJ, Bradley J, Feigenberg SJ, Yegya-Raman N Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors , Int J Radiat Oncol Biol Phys, 118(5): 2024,1435-1444